Entera Stock Performance

The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. Let's try to break down what Entera's beta means in this case. the returns on MARKET and Entera Bio are completely uncorrelated. Although it is important to respect Entera Bio historical returns, it is better to be realistic regarding the information on the equity's current trending patterns. The philosophy towards predicting future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By reviewing Entera Bio technical indicators, you can presently evaluate if the expected return of 0.0% will be sustainable into the future. Entera Bio right now shows a risk of 0.0%. Please confirm Entera Bio variance and potential upside to decide if Entera Bio will be following its price patterns.
  
Entera Performance
0 of 100
Over the last 90 days Entera Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Entera Bio is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Quick Ratio8.71
Fifty Two Week Low1.3100
Target High Price9.00
Fifty Two Week High5.8400
Target Low Price5.00

Entera Bio Relative Risk vs. Return Landscape

If you would invest (100.00)  in Entera Bio on May 12, 2022 and sell it today you would earn a total of  100.00  from holding Entera Bio or generate -100.0% return on investment over 90 days. Entera Bio is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Entera, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  

Entera Bio Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Entera Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Entera Bio, and traders can use it to determine the average amount a Entera Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
ENTX
Based on monthly moving average Entera Bio is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Entera Bio by adding it to a well-diversified portfolio.

Things to note about Entera Bio

Checking the ongoing alerts about Entera Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Entera Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Entera Bio Alerts

Equity Alerts and Improvement Suggestions

Entera Bio is not yet fully synchronised with the market data
Entera Bio has some characteristics of a very speculative penny stock
Entera Bio was previously known as Entera Bio and was traded on NASDAQ Exchange under the symbol ENTXW.
The company reported the previous year's revenue of 482 K. Net Loss for the year was (13.68 M) with profit before overhead, payroll, taxes, and interest of 198 K.
Entera Bio currently holds about 20.11 M in cash with (11.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.7.
Entera Bio has a poor financial position based on the latest SEC disclosures
Roughly 23.0% of the company shares are held by company insiders
Check out Investing Opportunities. Note that the Entera Bio information on this page should be used as a complementary analysis to other Entera Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Tools for Entera Stock

When running Entera Bio price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go